# Kraig Biocraft Files to Expand Investment License for Spider Silk Unit

- URL: https://stocks.freetheai.org/news/kraig-biocraft-files-to-expand-investment-license-for-spider-silk-unit-f4433b
- Published: 2026-10-12T11:05:00Z
- Category: company_news; sentiment: bullish; impact: medium
- Symbols: [OTC:KBLB](https://stocks.freetheai.org/symbols/OTC-KBLB)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Kraig Biocraft Laboratories, Inc. (OTC:KBLB) has filed to expand the investment license for its Prodigy Silk division. The move is designed to secure funding and build out infrastructure to support larger production volumes of recombinant spider silk. Following the announcement, shares of the company rose 2.88% to $0.093.

The application marks a transition for the business from pilot-scale testing toward early commercial delivery. Kraig Biocraft currently operates three rearing centers and established a monthly production record of 2.5 metric tons of cocoons in June. The company also completed its first commercial shipment of custom yarn.

Investors looking ahead will be monitoring for formal regulatory approval of the expanded license, detailed capital expenditure estimates, and any future supply contracts or revenue targets linked to the expanded facility.

## Key points

- Kraig Biocraft Laboratories, Inc. filed for an expanded investment license for its Prodigy Silk division.
- The filing aims to raise and deploy capital to construct infrastructure and scale recombinant spider silk capacity.
- The company currently runs three rearing centers and achieved a record output of 2.5 metric tons of cocoons in June.
- Kraig Biocraft has delivered its first custom yarn as it shifts from pilot testing into early commercialization.

## Questions and answers

### Why is Kraig Biocraft Laboratories expanding its investment license?

Kraig Biocraft Laboratories filed for an expanded license for its Prodigy Silk unit to secure funding for additional infrastructure and increase its recombinant spider silk manufacturing capacity.

### What recent production achievements has Kraig Biocraft reported?

The company currently operates three rearing facilities, achieved a milestone output of 2.5 metric tons of cocoons in June, and recently delivered its first custom yarn order.

### What are the next key milestones for Kraig Biocraft?

Key developments to monitor include official approval of the expanded investment license, detailed capital spending plans, and signed customer agreements for the added production volume.